Please login to the form below

Not currently logged in
Email:
Password:

Ridgeback Biotherapeutics

This page shows the latest Ridgeback Biotherapeutics news and features for those working in and with pharma, biotech and healthcare.

Merck and Ridgeback fulfil US deal for molnupiravir

Merck and Ridgeback fulfil US deal for molnupiravir

Merck &Co – known as MSD outside the US and Canada – and Ridgeback Biotherapeutics have announced that approximately 3.1 million courses of its investigational oral antiviral COVID-19 treatment, molnupiravir, have ... Speaking on behalf of Ridgeback

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...